Place of Origin:
China
Brand Name:
Anrate
Model Number:
ART103S
Animal-Origin-Free System, Safe & Compliant
Expressed in Pichia pastoris with zero animal-derived components throughout production. Fundamentally eliminates risks of blood-borne viruses, mycoplasma and prions, fully meeting biopharmaceutical regulatory compliance requirements.
Ultra-High Purity, Low Endotoxin
Purified by multi-step chromatography with ≥99% purity by SDS-PAGE, endotoxin ≤0.5 EU/mg and ultra-low host cell protein (HCP) residue. Clean formulation, non-toxic and highly cell-compatible.
Lyophilized Formulation, Fast Reconstitution
Porous lyophilized powder with excellent solubility, rapidly reconstituted at room temperature into a clear, precipitate-free solution. Suitable for both lab-scale trials and industrial large-volume media preparation.
Functionally Equivalent to Plasma-Derived HSA
Fully retains the biological activity of native human albumin, effectively promotes cell adhesion, proliferation and differentiation, and maintains protein stability. Can replace plasma-derived human albumin at a 1:1 ratio.
Large-Scale Capacity, Reliable Supply
Backed by Anrate's hundred-ton scale recombinant albumin industrial base, with large single-batch output and minimal batch-to-batch variation. Stable supply from research-grade to industrial-grade specifications.
| Item | Specification |
| Product Name | Recombinant Human Albumin (Lyophilized Powder) |
| CAS Number | 70024-90-7 |
| MDL Number | MFCD00081418 |
| Expression System | Recombinant Pichia pastoris |
| Appearance | Off-white porous lyophilized cake or powder |
| Purity | ≥99.0% (USP-NF 2023) |
| Protein Content | 95.0% – 110.0% |
| Molecular Weight | ~66.5 kDa |
| Endotoxin | ≤0.5 EU/mg |
| HCP Residue | ≤10 ng/g |
| pH | 6.4 – 7.4 |
| Pack Sizes | 10 g, 100 g, 1 kg (custom bulk sizes available) |
Core component of serum-free / chemically defined media, suitable for MSCs, immune cells (T/NK cells), CHO cells, HEK293 cells and various culture systems, as a replacement for plasma-derived albumin.
Stabilizer and protectant for recombinant protein drugs, monoclonal antibodies and ADC therapeutics, inhibiting protein aggregation and denaturation and extending formulation shelf life.
Key component of serum-free cell cryopreservation media, reducing cell damage during freezing and significantly improving post-thaw cell viability and activity.
Protein stabilizer and protectant for human and veterinary vaccine formulations, enhancing vaccine thermal stability.
Blocking agent, protein stabilizer and standard matrix for immunoassays such as ELISA, colloidal gold tests and Western Blot.
A1: CAS number 70024-90-7 corresponds to Recombinant Human Albumin (rHSA, also called recombinant human serum albumin). It is produced via recombinant DNA technology, different from plasma-derived human albumin.
A2: Yes. Anrate recombinant human albumin is expressed in Pichia pastoris system, with no animal-derived components used from raw materials to the entire production process. It has no blood-borne contamination risk and fully meets biopharmaceutical compliance requirements.
A3: Yes. Anrate recombinant human albumin is identical to native human albumin in amino acid sequence, spatial structure and biological function. It can replace plasma-derived human albumin (pHSA) at a 1:1 equivalent ratio in cell culture, formulation excipients and other scenarios, with higher safety and better batch consistency.
A4: Anrate recombinant human albumin lyophilized powder has ≥99% purity by SDS-PAGE, endotoxin ≤0.5 EU/mg, and HCP residue ≤10 ng/g, meeting the strict requirements of high-end cell culture and biopharmaceutical excipients.
A5: Yes. With hundred-ton scale production capacity, Anrate provides full-spec packaging from gram to kilogram and ton levels, supports customized services, and can stably meet the needs of research, pilot scale-up and industrial mass production.
WhatsApp: +85363312841 | Email: sales@bjanrate.cn
Send your inquiry directly to us